aucubin has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, DD; Ou, JS; Ou, ZJ | 1 |
Huang, HW; Huang, MS; Hung, JY; Tsai, YM; Yang, CJ | 1 |
2 other study(ies) available for aucubin and Lung Neoplasms
Article | Year |
---|---|
A potential agent for treating non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation, Preclinical; Glucosides; Humans; Iridoid Glucosides; Iridoids; Lung Neoplasms; Phytotherapy; Plant Extracts; Rats; Treatment Outcome; Tumor Cells, Cultured | 2008 |
Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells.
Topics: Antibodies; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, p53; Glucosides; Humans; Iridoid Glucosides; Iridoids; Lung Neoplasms | 2008 |